Ads

You May Also Like

Shire plc : Director Declaration

Director Declaration July 24, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") ...

Endoscopic Stricture Management Device Market to Gain US$ 992.99 Mn by 2026, Says TMR

Endoscopic Stricture Management Device Market: Shift from Invasive to Minimally Invasive Surgery and Technological ...

Argos Therapeutics Enters into Strategic Research Agreement with Adaptive Biotechnologies

DURHAM, N.C., June 15, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), an immuno-oncology ...